Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial. - Mähler A; Steiniger J; Bock M; Klug L; Parreidt N; Lorenz M; Zimmermann BF; Krannich A; Paul F; Boschmann M (The American journal of clinical nutrition, 2015)